Stock Events

Stock Events

Appili Therapeutics 

$0.009000
14
-$0.00-9.09% Monday 20:00

Statistics

Day High
0.0099
Day Low
0.0099
52W High
0.031
52W Low
0.008
Volume
10,000
Avg. Volume
9,558
Mkt Cap
1.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
Next
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,744.23%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
176,465.34Revenue
-3.08MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is a biopharmaceutical company that competes with Appili Therapeutics in the development of antiviral drugs, including treatments for infectious diseases.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines for infectious diseases, directly competing with Appili Therapeutics' focus areas.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including treatments for infectious diseases, making it a competitor.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie Inc. engages in the research and development of pharmaceutical products, including therapies for infectious diseases, competing with Appili's product pipeline.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical segment, develops treatments for infectious diseases, competing with Appili Therapeutics in this space.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb Company offers prescription pharmaceuticals in several therapeutic areas, including infectious diseases, making it a competitor to Appili Therapeutics.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca PLC is a biopharmaceutical company that develops and commercializes medicines for various diseases, including infections, competing with Appili Therapeutics.
Novartis
NVS
Mkt Cap286.78B
Novartis AG focuses on the discovery, development, and marketing of healthcare products, including treatments for infectious diseases, making it a competitor.
Sanofi
SNY
Mkt Cap104.76B
Sanofi is a healthcare company that develops and markets drugs with a focus on infectious diseases, directly competing with Appili Therapeutics.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline plc is a global healthcare company that researches and develops pharmaceuticals, vaccines, and healthcare products, including for infectious diseases, competing with Appili Therapeutics.

About

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections. It also develops ATI-1801, a topical formulation of paromomycin in a Phase III trial for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine in preclinical trials for the prevention of Francisella tularensis infection. The company has a collaboration with Vitalex Biosciences to advance VXV-01, a dual-antigen vaccine targeting invasive Candida infections. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Show more...
CEO
Don Cilla
Employees
7
Country
Canada
ISIN
CA03783R1073

Listings

V
CA
APLI.V
TO
CA
APLI.TO
OTC Link
US
APLIF

0 Comments

Share your thoughts

FAQ

What is Appili Therapeutics stock price today?▼
The current price of APLIF is $0.01 USD — it has decreased by -9.09% in the past 24 hours. Watch Appili Therapeutics stock price performance more closely on the chart.
What is Appili Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Appili Therapeutics stocks are traded under the ticker APLIF.
Is Appili Therapeutics stock price growing?▼
APLIF stock has risen by +0% compared to the previous week, the month change is a -11.76% fall, over the last year Appili Therapeutics has showed a -29.69% decrease.
What is Appili Therapeutics market cap?▼
Today Appili Therapeutics has the market capitalization of 1.19M
When is the next Appili Therapeutics earnings date?▼
Appili Therapeutics is going to release the next earnings report on November 12, 2026.
What is Appili Therapeutics revenue for the last year?▼
Appili Therapeutics revenue for the last year amounts to 176,465.34 USD.
What is Appili Therapeutics net income for the last year?▼
APLIF net income for the last year is -3.08M USD.
How many employees does Appili Therapeutics have?▼
As of August 19, 2026, the company has 7 employees.
In which sector is Appili Therapeutics located?▼
Appili Therapeutics operates in the Health & Wellness sector.
When did Appili Therapeutics complete a stock split?▼
Appili Therapeutics has not had any recent stock splits.
Where is Appili Therapeutics headquartered?▼
Appili Therapeutics is headquartered in Halifax, Canada.